Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes

Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes

Patients suffering from tissue ischemia, who would greatly benefit from angiogenesis-promoting therapies such as hypoxia preconditioned blood-derived secretomes commonly receive oral anticoagulation (OA) and/or have diabetes mellitus (DM). In this study, we investigated the effect of OA administrati...

Full description

Bibliographic Details
Main Authors: Philipp Moog, Maryna Jensch, Jessica Hughes, Burak Salgin, Ulf Dornseifer, Hans-Günther Machens, Arndt F. Schilling, Ektoras Hadjipanayi
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Biomedicines
Subjects:
acetylsalicylic acid
angiogenesis
blood-derived therapy
COX-1
clopidogrel
drug anticoagulation
Online Access:https://www.mdpi.com/2227-9059/8/8/283

Internet

https://www.mdpi.com/2227-9059/8/8/283

Similar Items